Amato, C.M.; Hintzsche, J.D.; Wells, K.; Applegate, A.; Gorden, N.T.; Vorwald, V.M.; Tobin, R.P.; Nassar, K.; Shellman, Y.G.; Kim, J.;
et al. Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers 2020, 12, 1943.
https://doi.org/10.3390/cancers12071943
AMA Style
Amato CM, Hintzsche JD, Wells K, Applegate A, Gorden NT, Vorwald VM, Tobin RP, Nassar K, Shellman YG, Kim J,
et al. Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers. 2020; 12(7):1943.
https://doi.org/10.3390/cancers12071943
Chicago/Turabian Style
Amato, Carol M., Jennifer D. Hintzsche, Keith Wells, Allison Applegate, Nicholas T. Gorden, Victoria M. Vorwald, Richard P. Tobin, Kelsey Nassar, Yiqun G. Shellman, Jihye Kim,
and et al. 2020. "Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy" Cancers 12, no. 7: 1943.
https://doi.org/10.3390/cancers12071943
APA Style
Amato, C. M., Hintzsche, J. D., Wells, K., Applegate, A., Gorden, N. T., Vorwald, V. M., Tobin, R. P., Nassar, K., Shellman, Y. G., Kim, J., Medina, T. M., Rioth, M., Lewis, K. D., McCarter, M. D., Gonzalez, R., Tan, A. -C., & Robinson, W. A.
(2020). Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers, 12(7), 1943.
https://doi.org/10.3390/cancers12071943
